Clinical Trials Logo

Arthritis clinical trials

View clinical trials related to Arthritis.

Filter by:

NCT ID: NCT04550884 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Neuropathic Foot and Ankle in Rheumatoid Arthritis : Ultrasound and Nerve Conduction Study

Start date: October 2020
Phase:
Study type: Observational

1. To measure the prevalence of Neuropathic pain in Rheumatoid arthritis patients with ankle and foot pain 2. To evaluate the role of Neuromuscular Ultra sound (NMUS) and nerve conduction study (NCS) in assessment of Neuropathic foot and ankle in Rheumatoid arthritis patients

NCT ID: NCT04535427 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis

Start date: January 1, 2021
Phase: Phase 2
Study type: Interventional

To investigate the role of L-arginine supplementation in the treatment of DMARDs-refractory moderate to severe rheumatoid arthritis

NCT ID: NCT04493762 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Liver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on Methotrexate

Start date: August 13, 2020
Phase:
Study type: Observational

While methotrexate (MTX) remains a treatment of choice for patients with rheumatoid arthritis (RA), psoriasis (PsO) and psoriatic arthritis (PsA), long-term MTX use has been shown to be associated with liver fibrosis and cirrhosis in these patients. In addition, gut dysbiosis has been found to be associated with liver fibrosis and cirrhosis via the gut-liver axis, underscoring the potential role of gut microbiota and bacterial translocation in the pathogenesis of chronic liver diseases in these patients. In this study, we aim to assess the prevalence of advanced liver fibrosis or cirrhosis among these patients on MTX treatment compared to those without, using transient elastography. We also aim to identify the possible risk factor(s) for advanced liver fibrosis or cirrhosis among them. Further, we aim to characterize the difference in fecal microbiota patterns among these three groups of patients. Using a cross-sectional, prospective cohort design, this study will enroll approximately 600 eligible patients, including 300 patients with PsO/PsA and 300 patients with RA, to examine the following hypotheses: 1. Patients on higher cumulative dose of MTX will have higher prevalence of advanced liver fibrosis or cirrhosis compared to those on lower cumulative dose of MTX; 2. Patients with MTX use will have higher prevalence of advanced liver fibrosis or cirrhosis compared to those without MTX use; 3. The fecal microbiota composition will be different between patients with and without MTX treatment; and 4. The fecal microbiota composition will be different between patients with and without advanced fibrosis/cirrhosis while on MTX treatment.

NCT ID: NCT04479462 Not yet recruiting - Arthritis Knee Clinical Trials

The Establishment of Total Joint Arthroplasty Registry Database

Start date: September 1, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this study will establish total joint arthroplasty registry database in Kaohsiung Chang Gung Memorial Hospital and collect patient-reported outcome.

NCT ID: NCT04465188 Not yet recruiting - Stickler Syndrome Clinical Trials

Scleral Buckling for Retinal Detachment Prevention in Genetically Confirmed Stickler Syndrome

STL-DR-PREV
Start date: June 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a scleral buckling surgical procedure performed on fellow eyes of patients with genetically confirmed Stickler syndrome can prevent the occurrence retinal detachment and/or severe vision loss of the study eye.

NCT ID: NCT04462666 Not yet recruiting - Gouty Arthritis Clinical Trials

Oral Huzhang Granules for Acute Gouty Arthritis

Start date: July 1, 2020
Phase: Phase 2
Study type: Interventional

We designed this study as a double-blind, randomized, controlled clinical trial. The aim of the study is to evaluate the clinical efficacy, safety and control of recurrence rate of acute gouty arthritis

NCT ID: NCT04435730 Not yet recruiting - Psoriasis Clinical Trials

Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients

Start date: October 2020
Phase:
Study type: Observational

Aims of the study: 1. Measurement of serum level of Mac 2 binding protein among patients with psoriasis, psoriatic arthritis and subclinical psoriatic arthritis compared with healthy individuals. 2. Evaluation of MSUS findings in patients with PsA and subclinical psoriatic arthritis 3. Evaluation of the role of serum level of Mac 2 binding protein and MSUS in predicting arthritis among psoriatic patients.

NCT ID: NCT04415502 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

CTHRC1: A Biomarker for Evaluation of Rheumatoid Arthritis Disease Activity

Start date: October 1, 2020
Phase:
Study type: Observational

The purpose of the study is to determine whether plasma levels of the collagen triple helix repeat containing (CTHRC1) protein can serve as a blood-based biomarker for diagnosis of rheumatoid arthritis (RA) ,and furthermore its correlation with disease activity

NCT ID: NCT04403958 Not yet recruiting - Wrist Arthritis Clinical Trials

The Use of Proximal Carpal Row Versus Iliac Crest as Bone Graft in Total Wrist Fusion

PROOF II
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Study purpose is to compare the outcome after total wrist arthrodesis (TWA) with proximal carpal row (Proximal Row Carpectomy = PRC) as bone graft versus iliac crest cancellous bone graft. Patients with radiologically and clinically confirmed advanced osteoarthritis are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo either total wrist arthrodesis with PRC or TWA with iliac crest bone grafting. Baseline data is collected preoperatively and is a follow-up visits at every 6 weeks after the surgery is arranged until the wrist is fused. The primary end-point is 6 months and the primary outcome is fusion rate.

NCT ID: NCT04380129 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Music Therapy Model "The Bonny Method of Guided Imagery and Music" on Patients With Rheumatoid Arthritis

GIM
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of music therapy and in particular of the model "The Bonny Method of Guided Imagery and Music (GIM)" in patients with rheumatoid arthritis (RA) in relation to both chronic pain relief and other psychosocial parameters, as well as the effect of the method on caregiver burden.